Atypical protein kinase C zeta as a target for chemosensitization of tumor cells.

Filomenko, Rodolphe; Poirson-Bichat, Florence; Billerey, Claire; Belon, Jean-Paul; Garrido, Carmen; Solary, Eric; Bettaieb, Ali

Filomenko, Rodolphe; Poirson-Bichat, Florence; Billerey, Claire; Belon, Jean-Paul; Garrido, Carmen; Solary, Eric; Bettaieb, Ali.

Affiliation

Filomenko R; INSERM U517, EPHE, Ecole Pratique des Hautes Etudes, IFR, Institut Féderatif de Recherche 100, Faculties of Medicine & Pharmacy, 21000 Dijon, France.

Cancer Res ; 62(6): 1815-21, 2002 Mar 15.

Article in En | MEDLINE | ID: mdl-11912160

Subject(s)

Antineoplastic Agents/pharmacology; Protein Kinase C/physiology; Apoptosis/drug effects; Enzyme Activation/drug effects; Etoposide/pharmacology; HT29 Cells/cytology; HT29 Cells/drug effects; HT29 Cells/enzymology; Humans; Mutation; Protein Kinase C/genetics; Protein Kinase C/metabolism; Tumor Necrosis Factor-alpha/pharmacology; U937 Cells/cytology; U937 Cells/drug effects; U937 Cells/enzymology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Protein Kinase C / Antineoplastic Agents Limits: Humans Language: En Journal: Cancer Res Year: 2002 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links